- Acuity suppression
- Amnesia
- Analysis enhancement
- Anxiety suppression
- Auditory distortion
- Auditory enhancement
- Auditory hallucinations
- Auditory suppression
- Autonomous entities
- Compulsive redosing
- Conceptual thinking
- Consciousness disconnection
- Déjà vu
- Depersonalization
- Derealization
- Disinhibition
- Dizziness
- Double vision
- Environmental cubism
- Environmental orbism
- External hallucinations
- Frame rate suppression
- Geometry
- Immersion enhancement
- Information processing suppression
- Internal hallucinations
- Memory suppression
- Motor control loss
- Nausea
- Pattern recognition suppression
- Perception of decreased weight
- Personal bias suppression
- Perspective alterations
- Perspective distortions
- Physical autonomy
- Physical euphoria
- Scenarios and plots
- Scenery slicing
- Settings, sceneries, and landscapes
- Spontaneous tactile sensations
- Subconscious communication
- Suggestibility enhancement
- Synaesthesia
- Tactile disconnection
- Tactile suppression
- Thought deceleration
- Time distortion
- Unity and interconnectedness
- Visual disconnection
- Visual sliding
Ketamine
Aliases: k, ket, kitty, kittens
Categories
Summary
A short acting dissociative anaesthetic and hallucinogen commonly used in emergency medicine. It is the prototypical dissociative, and is widely used at sub-anesthetic doses recreationally. Small doses are comparable with alcohol, while larger doses are immobilising and lead to psychedelic experiences: the "K-Hole."
Dose Information
Onset, Duration & After-effects
- Onset:
- Insufflated: 7.5-20 minutes
- Intramuscular: 2-7.5 minutes
- Intravenous: 0-2 minutes
- Oral: 10-75 minutes
- Duration: 1-2 hours
- After-effects: 1-2 hours
Effects
- A feeling of drunkenness and well being at low doses
- As dose increases the user may begin to feel a disconnection from their body
- At 'khole' doses the user may become completely disconnected from both body and mind
Helpful Links
Known Combinations
These combinations are considered extremely harmful and should always be avoided.
alcohol: Both substances cause ataxia and bring a very high risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.
ghb/gbl: Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.
opioids: Both substances bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.
These combinations are not usually physically harmful, but may produce undesirable effects.
amphetamines: No unexpected interactions, though likely to increase blood pressure but not an issue with sensible doses. Moving around on high doses of this combination may be ill advised due to risk of physical injury.
benzodiazepines: Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position.
cocaine: No unexpected interactions, though likely to increase blood pressure but not an issue with sensible doses. Moving around on high doses of this combination may be ill advised due to risk of physical injury.
maois: MAO-B inhibitors appear to increase the potency of Ketamine. MAO-A inhbitors have some negative reports associated with the combination but there isn't much information available
These drugs work together to cause an effect greater than the sum of their parts.
dextromethorphan: Both substances primarily exert their effects through NMDA antagonism. Currently, there is no evidence regarding mechanisms that might reduce these effects.
dox: Ketamine and psychedelics tend to potentiate each other - go slowly.
mdma: No unexpected interactions, though likely to increase blood pressure but not an issue with sensible doses. Moving around on high doses of this combination may be ill advised due to risk of physical injury.
Effects are additive. The combination is unlikely to cause any adverse or undesirable reaction.
caffeine: No unexpected interactions.
Studies
- Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model ps..
- The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations
- Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome
- Effects of ketamine on precipitated opiate withdrawal
- Low-dose ketamine with multimodal postcesarean delivery analgesia: a randomized controlled trial
- Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys
- GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects
- From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine
- Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial
- Brain damages in ketamine addicts as revealed by magnetic resonance imaging
- Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
- Are sexes affected differently by ketamine? An exploratory study in ketamine users
- Therapeutic infusions of ketamine: do the psychoactive effects matter
- The absolute bioavailability of racemic ketamine from a novel sublingual formulation
- The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model..
- The promise of ketamine for treatment-resistant depression: current evidence and future directions
- Antidepressants do not increase the lethality of ketamine in mice
- Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain
- Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children
- Tissue distribution of ketamine in a mixed drug fatality
- [From the racemate to the eutomer: (S)-ketamine. Renaissance of a substance?]
- Chronic abuse has led to a case of kidney and liver damage http://www.ncbi.nlm.nih.gov/pubmed/24982568
- ketamine in the hospital setting can raise blood pressure and is something to be considered when using it: "Emergency care in the streets"
- Ketamine shows promise in treating suicidal ideation in patients with depression